People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Other Health Care, Other Technology, Biotechnology, Pharmaceuticals, Other, Manufacturing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Glooko, Inc. | — | Other Health Care | Series D+ | $221.0M | $1.2B | 2021 |
| Transcend Medical Inc | — | Other Health Care | Series B | $122.3M | $648.4M | 2009 |
| Revision Optics Inc | — | Other Technology | Series B | $121.7M | $973.8M | 2010 |
| Dermira, Inc. | — | Other Health Care | Series C | $113.0M | $22.9M | 2011 |
| OncoResponse Inc | — | Biotechnology | Series C | $109.0M | $39.3M | 2015 |
| Antiva Biosciences, Inc. | — | Biotechnology | Series B | $96.8M | $457.3M | 2015 |
| Qlaris Bio, Inc. | — | Biotechnology | Series B | $37.8M | $22.3M | 2019 |
| Theraclone Sciences, Inc. | — | Biotechnology | Series A | $36.7M | $111.3M | 2010 |
| Hyalex Orthopaedics, Inc. | — | Other Health Care | Series B | $30.4M | $91.1M | 2017 |
| Stargazer Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $28.5M | $967.8M | 2018 |
| ALDEA Pharmaceuticals, Inc. | — | Biotechnology | Series A | $27.5M | $334.9M | 2011 |
| Altheos, Inc. | — | Other | Series B | $23.1M | $275.1M | 2011 |
| Calibra Medical, Inc. | — | Other Health Care | Series A | $19.8M | $163.7M | 2009 |
| Labrys Biologics, Inc. | — | Pharmaceuticals | Series A | $14.6M | $451.8M | 2012 |
| Butterfly Health, Inc. | — | Manufacturing | Series A | $13.6M | $30.5M | 2012 |
| Apieron Inc | — | Other Health Care | Series A | $5.9M | $119.6M | 2009 |
Wende Hutton at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Wende Hutton on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven Gillis | 2 | 23 |
| Clifford Stocks | 2 | 5 |
| Kristine Swiderek | 2 | 2 |
| Russ Hawkinson | 2 | 2 |
| Wende S. Hutton | 2 | 2 |
| John Walker | 1 | 17 |
| Andrew Perlman | 1 | 15 |
| Steve Gillis | 1 | 13 |
| David Martin | 1 | 13 |
| Corey Goodman | 1 | 13 |
| John Wagner | 1 | 10 |
| Jennifer Fonstad | 1 | 9 |
| Timothy Shannon | 1 | 9 |
| Peter Bisgaard | 1 | 9 |
| Richard Lin | 1 | 8 |
| Charles Boorady | 1 | 8 |
| Reza Zadno | 1 | 7 |
| Brian H. Dovey | 1 | 7 |
| Hoyoung Huh | 1 | 7 |
| David Kabakoff | 1 | 7 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.